SITAGLIPTIN Metformin NOBEL 50/500 mg 56 pce
7680689670010
CH-68967
A10BD07
07.06.2.
Active substances:
1 / 3
google
Details
- GTIN
- 7680689670010
- Pharmacode
- -
- Product number
- 6896701
- CPT
- -
- Packaging group
- 56
- Unit
- Tablette(n)
- Composition
- sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum 56.69 mg, metformini hydrochloridum 500 mg, povidonum K 30, cellulosum microcristallinum, crospovidonum, natrii stearylis fumaras corresp. natrium 0.765 mg, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto.
Articles (1)
Sitagliptin Metformin NOBEL 50 mg/500 mg, Filmtabletten
Filmtabletten
56
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
sitagliptinum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
sitagliptini hydrochloridum monohydricum
|
56.69 MG | Substance | WIZUS |
|
metformini hydrochloridum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
povidonum K 30
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
crospovidonum
|
- | Substance | HNIDK |
|
natrii stearylis fumaras
|
- | Substance | HNIDK |
|
natrium
|
0.765 MG | Substance | HBESI |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 26.75
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/05/2025
Authorization holder
NOBEL Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 68967
- Drug name
- Sitagliptin Metformin NOBEL, Filmtabletten
- Galenic form
- FILM
- ATC Code
- A10BD07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/12/2023
- Authorization expiration date
- 27/12/2028
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SITAGLIPTIN Metformin NOBEL 50/500 mg 56 pce
- Description (DE)
- SITAGLIPTIN Metformin NOBEL 50/500 mg 56 Stk
- Market launch
- 01/05/2025
- Narcotic (BTM)
- No